Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)
South Korea · Delayed Price · Currency is KRW 87,100
+2,800 (3.32%)
Apr 10, 2026, 3:30 PM KST
Mezzion Pharma Market Cap
Mezzion Pharma has a market cap or net worth of 2.65 trillion as of April 10, 2026. Its market cap has increased by 221.14% in one year.
Market Cap
2.65T
Enterprise Value
2.63T
Revenue
7.91B
Ranking
n/a
PE Ratio
n/a
Stock Price
87,100.00
Market Cap Chart
Since January 20, 2012, Mezzion Pharma's market cap has increased from 240.02B to 2.65T, an increase of 1,002.48%. That is a compound annual growth rate of 18.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 2.56T | -6.38% |
| Dec 30, 2025 | 2.74T | 195.96% |
| Dec 30, 2024 | 924.37B | -19.89% |
| Dec 28, 2023 | 1.15T | 231.92% |
| Dec 29, 2022 | 347.65B | -82.01% |
| Dec 30, 2021 | 1.93T | 23.60% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.97T |
| Celltrion | 44.18T |
| ALTEOGEN | 20.04T |
| Samsung Epis Holdings | 12.08T |
| D&D Pharmatech | 2.94T |
| PharmaResearch | 2.94T |
| ST Pharm | 2.91T |
| Hugel | 2.68T |